These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 24265137

  • 1. Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat.
    Kono S, Deguchi K, Omote Y, Yunoki T, Yamashita T, Kurata T, Ikeda Y, Abe K.
    J Neurosci Res; 2014 Jan; 92(1):46-53. PubMed ID: 24265137
    [Abstract] [Full Text] [Related]

  • 2. Rivaroxaban and apixaban reduce hemorrhagic transformation after thrombolysis by protection of neurovascular unit in rat.
    Kono S, Yamashita T, Deguchi K, Omote Y, Yunoki T, Sato K, Kurata T, Hishikawa N, Abe K.
    Stroke; 2014 Aug; 45(8):2404-10. PubMed ID: 24984746
    [Abstract] [Full Text] [Related]

  • 3. Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke.
    Kate M, Szkotak A, Witt A, Shuaib A, Butcher K.
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1351-5. PubMed ID: 24406026
    [Abstract] [Full Text] [Related]

  • 4. Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.
    Pfeilschifter W, Bohmann F, Baumgarten P, Mittelbronn M, Pfeilschifter J, Lindhoff-Last E, Steinmetz H, Foerch C.
    Ann Neurol; 2012 May; 71(5):624-33. PubMed ID: 22447744
    [Abstract] [Full Text] [Related]

  • 5. Effects of Pretreatment with Warfarin or Rivaroxaban on Neurovascular Unit Dissociation after Tissue Plasminogen Activator Thrombolysis in Ischemic Rat Brain.
    Shang J, Yamashita T, Kono S, Morihara R, Nakano Y, Fukui Y, Li X, Hishikawa N, Ohta Y, Abe K.
    J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):1997-2003. PubMed ID: 27230587
    [Abstract] [Full Text] [Related]

  • 6. Treatment of acute stroke in patients on dabigatran: a survey of US stroke specialists.
    Rybinnik I, Mullen MT, Messe S, Kasner SE, Cucchiara B.
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1312-6. PubMed ID: 23313461
    [Abstract] [Full Text] [Related]

  • 7. Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization.
    Sangha N, El Khoury R, Misra V, Lopez G.
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):917.e5-8. PubMed ID: 22683118
    [Abstract] [Full Text] [Related]

  • 8. Reduction of intracerebral hemorrhage by rivaroxaban after tPA thrombolysis is associated with downregulation of PAR-1 and PAR-2.
    Morihara R, Yamashita T, Kono S, Shang J, Nakano Y, Sato K, Hishikawa N, Ohta Y, Heitmeier S, Perzborn E, Abe K.
    J Neurosci Res; 2017 Sep; 95(9):1818-1828. PubMed ID: 28035779
    [Abstract] [Full Text] [Related]

  • 9. Good outcome after intravenous thrombolysis for acute stroke in a patient under treatment with dabigatran.
    Diogo C, Duarte J, Sobral S, Pestana P, Nzwalo H, Rita H, Sousa E Costa J.
    Am J Emerg Med; 2014 Nov; 32(11):1435.e1-2. PubMed ID: 24881517
    [Abstract] [Full Text] [Related]

  • 10. Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator.
    Bissig D, Manjunath R, Traylor BR, Richman DP, Ng KL.
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):e102-e104. PubMed ID: 28416406
    [Abstract] [Full Text] [Related]

  • 11. Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.
    Casado Naranjo I, Portilla-Cuenca JC, Jiménez Caballero PE, Calle Escobar ML, Romero Sevilla RM.
    Cerebrovasc Dis; 2011 Jun; 32(6):614-5. PubMed ID: 22133608
    [No Abstract] [Full Text] [Related]

  • 12. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
    Zhang Y, Wang Y, Zuo Z, Wang Z, Roy J, Hou Q, Tong E, Hoffmann A, Sperberg E, Bredno J, Berr SS, Xie M, Lee K, Wintermark M.
    J Neurol Sci; 2014 Dec 15; 347(1-2):148-54. PubMed ID: 25292413
    [Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Freeman JV, Zhu RP, Owens DK, Garber AM, Hutton DW, Go AS, Wang PJ, Turakhia MP.
    Ann Intern Med; 2011 Jan 04; 154(1):1-11. PubMed ID: 21041570
    [Abstract] [Full Text] [Related]

  • 14. [Direct oral thrombin inhibitor, "dabigatran"].
    Yasaka M.
    Nihon Rinsho; 2013 Jan 04; 71(1):113-8. PubMed ID: 23631181
    [Abstract] [Full Text] [Related]

  • 15. Thrombolysis in an ischemic stroke patient on dabigatran anticoagulation: a case report.
    Marrone LC, Marrone AC.
    Cerebrovasc Dis; 2012 Jan 04; 34(3):246-7. PubMed ID: 23018342
    [No Abstract] [Full Text] [Related]

  • 16. Intravenous tissue plasminogen activator treatment for ischemic stroke in dabigatran-treated patients.
    Takeuchi S, Wada K, Nagatani K, Otani N, Osada H, Nawashiro H.
    Acta Neurochir (Wien); 2012 Jan 04; 154(1):87. PubMed ID: 22037979
    [No Abstract] [Full Text] [Related]

  • 17. Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.
    Jin R, Xiao AY, Liu S, Wang M, Li G.
    Stroke; 2018 Jul 04; 49(7):1708-1718. PubMed ID: 29844028
    [Abstract] [Full Text] [Related]

  • 18. Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia.
    Sun L, Zhou W, Ploen R, Zorn M, Veltkamp R.
    Thromb Haemost; 2013 Jul 04; 110(1):153-61. PubMed ID: 23615682
    [Abstract] [Full Text] [Related]

  • 19. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
    Liu W, Hendren J, Qin XJ, Liu KJ.
    Stroke; 2009 Jul 04; 40(7):2526-31. PubMed ID: 19478225
    [Abstract] [Full Text] [Related]

  • 20. Dabigatran, intracranial hemorrhage, and the neurosurgeon.
    Awad AJ, Walcott BP, Stapleton CJ, Yanamadala V, Nahed BV, Coumans JV.
    Neurosurg Focus; 2013 May 04; 34(5):E7. PubMed ID: 23634926
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.